BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19186351)

  • 21. A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale.
    Haddow LJ; Floyd S; Copas A; Gilson RJ
    PLoS One; 2013; 8(4):e61826. PubMed ID: 23613945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shifting.
    Robbins RN; Remien RH; Mellins CA; Joska JA; Stein DJ
    AIDS Patient Care STDS; 2011 Oct; 25(10):587-93. PubMed ID: 21919734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder.
    Molinaro M; Sacktor N; Nakigozi G; Anok A; Batte J; Kisakye A; Myanja R; Nakasujja N; Robertson KR; Gray RH; Wawer MJ; Saylor D
    J Acquir Immune Defic Syndr; 2020 Mar; 83(3):278-283. PubMed ID: 32032278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South Africa.
    Goodkin K; Hardy DJ; Singh D; Lopez E
    J Neuropsychiatry Clin Neurosci; 2014; 26(4):352-8. PubMed ID: 26037857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C-infected population in India.
    Riedel D; Ghate M; Nene M; Paranjape R; Mehendale S; Bollinger R; Sacktor N; McArthur J; Nath A
    J Neurovirol; 2006 Feb; 12(1):34-8. PubMed ID: 16595372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simple screening for neurocognitive impairment in routine HIV outpatient care: is it deliverable?
    Parry S; Zetler S; Kentridge A; Petrak J; Barber T
    AIDS Care; 2017 Oct; 29(10):1275-1279. PubMed ID: 28292203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic utility of the HIV dementia scale and the international HIV dementia scale in screening for HIV-associated neurocognitive disorders among Spanish-speaking adults.
    López E; Steiner AJ; Smith K; Thaler NS; Hardy DJ; Levine AJ; Al-Kharafi HT; Yamakawa C; Goodkin K
    Appl Neuropsychol Adult; 2017; 24(6):512-521. PubMed ID: 27712132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of neurocognitive disorders and depression in a Brazilian HIV population.
    Troncoso FT; Conterno Lde O
    Rev Soc Bras Med Trop; 2015; 48(4):390-8. PubMed ID: 26312927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.
    Skinner S; Adewale AJ; DeBlock L; Gill MJ; Power C
    HIV Med; 2009 Apr; 10(4):246-52. PubMed ID: 19187172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND.
    Chalermchai T; Valcour V; Sithinamsuwan P; Pinyakorn S; Clifford D; Paul RH; Tipsuk S; Fletcher JL; Degruttola V; Ratto-Kim S; Hutchings N; Shikuma C; Ananworanich J;
    J Neurovirol; 2013 Apr; 19(2):137-43. PubMed ID: 23483520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.
    Choi Y; Townend J; Vincent T; Zaidi I; Sarge-Njie R; Jaye A; Clifford DB
    J Neurovirol; 2011 Apr; 17(2):166-75. PubMed ID: 21424866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability of the lay adherence counsellor administered substance abuse and mental illness symptoms screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa.
    Breuer E; Stoloff K; Myer L; Seedat S; Stein DJ; Joska J
    AIDS Behav; 2012 Aug; 16(6):1464-71. PubMed ID: 22001934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epilepsy-associated neurocognitive disorders (EAND) in an onchocerciasis-endemic rural community in Cameroon: A population-based case-control study.
    Njamnshi AK; Chokote ES; Ngarka L; Nfor LN; Tabah EN; Atchou JGB; Angwafor SA; Nkouonlack C; Mengnjo MK; Njamnshi WY; Dema F; Tatah GY; Zoung-KanyiBissek AC; Annoni JM; Ruffieux N
    Epilepsy Behav; 2020 Nov; 112():107437. PubMed ID: 32920377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon.
    Kanmogne GD; Kuate CT; Cysique LA; Fonsah JY; Eta S; Doh R; Njamnshi DM; Nchindap E; Franklin DR; Ellis RJ; McCutchan JA; Binam F; Mbanya D; Heaton RK; Njamnshi AK
    BMC Neurol; 2010 Jul; 10():60. PubMed ID: 20626870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.
    Ding Y; Lin H; Shen W; Wu Q; Gao M; He N
    J Neuroimmune Pharmacol; 2017 Dec; 12(4):661-669. PubMed ID: 28470583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Education effects on the International HIV Dementia Scale.
    Waldrop-Valverde D; Nehra R; Sharma S; Malik A; Jones D; Kumar AM; Ownby RL; Wanchu A; Weiss S; Prabhakar S; Kumar M
    J Neurovirol; 2010 Jul; 16(4):264-7. PubMed ID: 20578972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Montreal Cognitive Assessment-Basic (MoCA-B) is not a reliable screening tool for cognitive decline in HIV patients receiving combination antiretroviral therapy in rural South Africa.
    Hakkers CS; Beunders AJM; Ensing MHM; Barth RE; Boelema S; Devillé WLJ; Tempelman HA; Coutinho RA; Hoepelman AIM; Arends JE; van Zandvoort MJE
    Int J Infect Dis; 2018 Feb; 67():36-40. PubMed ID: 29183843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection.
    Lopardo GD; Bissio E; Iannella Mdel C; Crespo AD; Garone DB; Cassetti LI
    J Acquir Immune Defic Syndr; 2009 Dec; 52(4):488-92. PubMed ID: 19654553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cognition disorders in HIV infection. Validation of a brief neuropsychological evaluation battery].
    Desi M; Seibel N; Korezlioglu J; Silvestre D; Linard F
    Encephale; 1995; 21(4):289-94. PubMed ID: 7588168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature.
    Zipursky AR; Gogolishvili D; Rueda S; Brunetta J; Carvalhal A; McCombe JA; Gill MJ; Rachlis A; Rosenes R; Arbess G; Marcotte T; Rourke SB
    AIDS; 2013 Sep; 27(15):2385-401. PubMed ID: 23751261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.